This is positive news - this long awaited catalyst should ignite renewed buying and give RVX the push it needs. In terms of probability - does anyone know the stats on succesful Phase III trials with a positive safety data announcement? I would expect a significant increase in probability of a succesful trial based on this information.
Chicagoest